MİGREN HASTALARINDA TAMPA KİNESIOFOBİ ÖLÇEĞİNİN GEÇERLİLİĞİ VE GÜVENİLİRLİĞİ

Abstract

Özet Arka plan: Hareket korkusu, hareketin ağrıyı şiddetlendireceğini düşündüklerinde insanların aktivitelerini kısıtlamalarına neden olabilir. Genellikle kinezyofobi olarak tanımlanan bu yanıt, migrenli bireylerin önemli bir bölümünde bildirilmiştir. Hareketle ilgili korku, kalıcı ağrının yönetimine ve rehabilitasyona katılımı engelleyebileceğinden, doğru ölçümü klinik açıdan önemlidir. Şu anda, migrende özel bir kinezyofobi ölçümünün kullanılmasına ilişkin psikometrik kanıtlar yetersizdir. Amaçlar: Bu araştırmanın amacı, migrenli yetişkinlerde Tampa Kinezyofobi Ölçeği'nin (TSK) zamansal istikrarını ve yapı geçerliliğini değerlendirmektir. Yöntemler: Yüz on iki migrenli yetişkin değerlendirildi. Psikometrik değerlendirme, TSK'nın yanı sıra Migren Engellilik Değerlendirme Ölçeği (MIDAS), Beck Depresyon Envanteri (BDI) ve Ağrı Felaketleştirme Ölçeği (PCS) içeriyordu. Önceden belirlenmiş yapı geçerliliği hipotezlerini test etmek için bu ölçümler arasındaki ilişkiler incelendi. Zaman içindeki istikrar, TSK'nın 3-7 gün arayla iki kez uygulanmasıyla araştırıldı. Sonuçlar: Tekrarlanan TSK ölçümleri güçlü bir istikrar gösterdi (ICC=0,895). Baş ağrısı sıklığı ile ilişki orta düzeydeydi, oysa genel migren sakatlığı, ağrı yoğunluğu, depresif semptomlar ve ağrı felaketleştirme ile ilişkiler güçlüydü (sırasıyla rho=0,378, 0,858, 0,796, 0,878 ve 0,788). ROC analizinde hastalık şiddetinin ayırt edilmesi de yüksekti (AUC=0,924). 39,500 eşik değeri %90 duyarlılık ve %86 özgüllük sağladı. Sonuç: Bu bulgular, TSK'nın migrende hareketle ilişkili korkuyu ölçmek için kullanıldığında tatmin edici ila mükemmel psikometrik özelliklere sahip olduğunu göstermektedir. Bu nedenle, bu araç bu popülasyonda hem klinik değerlendirmeyi hem de araştırmayı destekleyebilir.

Keywords

• migren
• kinezyofobi
• tampa kinezyofobi ölçeği

Supporting Institution

Yok

Ethical Statement

Yok

Thanks

Yok

Validity and Reliability of the Tampa Kinesiophobia Scale in Migraine Patients

Abstract

Purpose: Fear-of-movement may cause people to restrict activity when they expect movement to intensify pain. This response, commonly described as kinesiophobia, has been reported in a substantial proportion of individuals with migraine (IwM). Because movement-related fear can interfere with the management of persistent pain and with participation in rehabilitation, its accurate measurement is clinically important. At present, psychometric evidence for using a dedicated kinesiophobia measure in migraine remains insufficient. The purpose of this investigation was to evaluate the temporal stability and construct validity of the Tampa Scale of Kinesiophobia (TSK) in IwM. Method: One hundred and twelve IwM were evaluated. The psychometric assessment included the TSK together with the Migraine Disability Assessment Scale (MIDAS), Beck Depression Inventory (BDI), and Pain Catastrophizing Scale (PCS). Relationships between these measures were examined to test prespecified construct-validity hypotheses. Stability over time was investigated by administering the TSK on two occasions separated by 3-7 days. Results: Repeated TSK measurements demonstrated strong stability (ICC=0.89). The association between TSK and headache frequency was weak (rho=0.37), whereas the associations with overall migraine disability (rho=0.85) and depressive symptoms (rho=0.87) were very strong, and those with pain intensity (rho=0.79) and pain catastrophizing (rho=0.78) were strong. Discrimination of disease severity was also high in ROC analysis (AUC=0.92). A threshold of 39.50 yielded 86% sensitivity and 90% specificity. Discussion: These findings provide evidence that the TSK has satisfactory-to-excellent psychometric properties when used to quantify movement-related fear in migraine. The instrument may therefore support both clinical evaluation and research in this population.

Keywords

• Kinesiophobia
• Migraine
• Tampa Kinesiophobia Scale

Supporting Institution

none.

Ethical Statement

none.

Thanks

none.

References

1. Benatto MT, Bevilaqua-Grossi D, Carvalho GF, Bragatto MM, Pinheiro CF, Straceri Lodovichi S, et al. Kinesiophobia Is Associated with Migraine. Pain Med. 2019;20(4):846-51.
2. Kese B, Salcı Y, Yılmaz Ö T. Validity and reliability of the Tampa Kinesiophobia-Fatigue Scale in patients with multiple sclerosis. Ir J Med Sci. 2022.
3. Martins IP, Gouveia RG, Parreira E. Kinesiophobia in migraine. J Pain. 2006;7(6):445-51.
4. Altay H, Celenay ST. An investigation of the relationship between cutaneous allodynia and kinesiophobia, gastrointestinal system symptom severity, physical activity and disability in individuals with migraine. Korean J Pain. 2023;36(1):137-46.
5. La Touche R, Fernández Pérez JJ, Proy Acosta A, González Campodónico L, Martínez García S, Adraos Juárez D, et al. Is aerobic exercise helpful in patients with migraine? A systematic review and meta-analysis. Scand J Med Sci Sports. 2020;30(6):965-82.
6. Carvalho GF, Schwarz A, Szikszay TM, Adamczyk WM, Bevilaqua-Grossi D, Luedtke K. Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice. Braz J Phys Ther. 2020;24(4):306-17.
7. Yilmaz ÖT, Yakut Y, Uygur F, Uluğ N. Tampa Kinezyofobi Ölçeği’nin Türkçe versiyonu ve test-tekrar test güvenirliği. Fizyoterapi Rehabilitasyon. 2011;22(1):44-9.
8. Bränström H, Fahlström M. Kinesiophobia in patients with chronic musculoskeletal pain: differences between men and women. J Rehabil Med. 2008;40(5):375-80.

9. Burwinkle T, Robinson JP, Turk DC. Fear of movement: factor structure of the tampa scale of kinesiophobia in patients with fibromyalgia syndrome. J Pain. 2005;6(6):384-91.
10. Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317-32.
11. Vlaeyen JWS, Kole-Snijders AMJ, Boeren RGB, van Eek H. Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance. Pain. 1995;62(3):363-72.
12. Lundberg M, Larsson M, Ostlund H, Styf J. Kinesiophobia among patients with musculoskeletal pain in primary healthcare. J Rehabil Med. 2006;38(1):37-43.
13. Bryman A, Cramer D. Quantitative data analysis with SPSS release 10 for Windows: A guide for social scientists: Routledge; 2002.
14. Garrigós-Pedrón M, La Touche R, Navarro-Desentre P, Gracia-Naya M, Segura-Ortí E. Effects of a Physical Therapy Protocol in Patients with Chronic Migraine and Temporomandibular Disorders: A Randomized, Single-Blinded, Clinical Trial. J Oral Facial Pain Headache. 2018;32(2):137-50.
15. Ertaş M, Siva A, Dalkara T, Uzuner N, Dora B, Inan L, et al. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2004;44(8):786-93.
16. Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache. 2013;53(1):81-92.
17. Yalinay Dikmen P, Yavuz BG, Aydinlar EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015;115(2):117-22.
18. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. COSMIN checklist manual. Amsterdam: University Medical Center. 2012.
19. Hisli N. Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi.(A reliability and validity study of Beck Depression Inventory in a university student sample). J Psychol. 1989;7:3-13.
20. Süren M, Okan I, Gökbakan AM, Kaya Z, Erkorkmaz U, Arici S, et al. Factors associated with the pain catastrophizing scale and validation in a sample of the Turkish population. Turk J Med Sci. 2014;44(1):104-8.
21. Prion S, Haerling KA. Making sense of methods and measurement: Spearman-Rho ranked-order correlation coefficient. Clin Simul Nurs. 2014;10(10):535-6.
22. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877-97.
23. Demirkirkan MK, Ellidokuz H, Boluk A. Prevalence and clinical characteristics of migraine in university students in Turkey. Tohoku J Exp Med. 2006;208(1):87-92.
24. Georgoudis G, Raptis K, Koutserimpas C. Cognitive Assessment of Musculoskeletal Pain: Validity and Reliability of the Greek Version of the Tampa Scale of Kinesiophobia in Patients Suffering from Chronic Low Back Pain. Maedica (Bucur). 2022;17(4):826-32.
25. Areeudomwong P, Buttagat V. Reliability and Validity of the Cross-Culturally Adapted Thai Version of the Tampa Scale for Kinesiophobia in Knee Osteoarthritis Patients. Malays J Med Sci. 2017;24(2):61-7.
26. Monticone M, Ferrante S, Ambrosini E, Rocca B, Secci C, Foti C. Development of the Tampa Scale of Kinesiophobia for Parkinson's disease: confirmatory factor analysis, reliability, validity and sensitivity to change. Int J Rehabil Res. 2015;38(2):113-20.
27. Askary-Ashtiani A, Ebrahimi-Takamejani I, Torkaman G, Amiri M, Mousavi SJ. Reliability and validity of the Persian versions of the fear avoidance beliefs questionnaire and Tampa Scale of Kinesiophobia in patients with neck pain. Spine (Phila Pa 1976). 2014;39(18):E1095-102.
28. Monticone M, Giorgi I, Baiardi P, Barbieri M, Rocca B, Bonezzi C. Development of the Italian version of the Tampa Scale of Kinesiophobia (TSK-I): cross-cultural adaptation, factor analysis, reliability, and validity. Spine (Phila Pa 1976). 2010;35(12):1241-6.
29. Aguiar AS, Bataglion C, Visscher CM, Bevilaqua Grossi D, Chaves TC. Cross-cultural adaptation, reliability and construct validity of the Tampa scale for kinesiophobia for temporomandibular disorders (TSK/TMD-Br) into Brazilian Portuguese. J Oral Rehabil. 2017;44(7):500-10.
30. Bland, J. M., & Altman, D. G. (1997). Statistics notes: Cronbach's alpha. Bmj, 314(7080), 572.
31. Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., ... & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of clinical epidemiology, 60(1), 34-42.
32. Kumar, R., & Indrayan, A. (2011). Receiver operating characteristic (ROC) curve for medical researchers. Indian pediatrics, 48, 277-287.